APRIORI
LIVE

Serial Number

97287505

Owner

APRIORI BIO, INC.

Attorney

Christina M. Licursi

First Use Date

May 29, 2026

Filing Date

Feb 28, 2022

Add to watchlist:

No watchlists yet
View on USPTO

APRIORI Trademark

Serial Number: 97287505

APRIORI is a trademark filed by APRIORI BIO, INC. on February 28, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

APRIORI BIO, INC. (2 trademarks)

CAMBRIDGE, MA 02142

Entity Type: 03

Flagship Labs 77, Inc.

55 Cambridge Parkway, Suite 800E
Cambridge, MA 02142

Entity Type: 03

Trademark Details

Filing Date

February 28, 2022

Registration Date

Not Registered

First Use Anywhere

May 29, 2026

First Use in Commerce

May 29, 2026

Published for Opposition

April 4, 2023

Goods & Services

Technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticals; research and development in the field of computational biology, bioinformatics, genomics, biotechnology, immunology and pharmaceuticals; Software as a service (SAAS) services featuring software for data analysis in the fields of biomedical and genomic research; software as a service (SAAS) services featuring software for the design and characterization of biologic therapeutic products and drug analysis in drug discovery and development; software as a service (SAAS) services featuring software for predictive analytics in the fields of biomedical and genomic research

Therapeutic products for the treatment of disease, namely, therapeutic pharmaceuticals for the treatment of viral diseases and infectious diseases; pharmaceutical preparations and products for the treatment of viral diseases and infectious diseases; vaccines; chemical reagents for medical purposes; diagnostic products for the diagnosis of disease or health status, namely, diagnostic preparations for medical use

Reagents for scientific or medical research use; reagents for research purposes in the field of drug discovery and development

Filing History

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jun 10, 2026 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jun 10, 2026 CNPR
ASSIGNED TO EXAMINER
Jun 9, 2026 DOCK
STATEMENT OF USE PROCESSING COMPLETE
Jun 3, 2026 SUPC
USE AMENDMENT FILED
May 29, 2026 IUAF
TEAS STATEMENT OF USE RECEIVED
May 29, 2026 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 1, 2026 EXRA
SOU EXTENSION 5 GRANTED
Apr 30, 2026 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 30, 2026 AITU
SOU TEAS EXTENSION RECEIVED
Nov 25, 2025 EEXT
SOU EXTENSION 5 FILED
Nov 24, 2025 EXT5
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 15, 2025 EXRA
SOU EXTENSION 4 GRANTED
May 29, 2025 EX4G
SOU EXTENSION 4 FILED
May 28, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
May 28, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2025 EXRA
SOU EXTENSION 3 GRANTED
Nov 26, 2024 EX3G
SOU EXTENSION 3 FILED
Nov 26, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Nov 26, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 30, 2024 EXRA
SOU EXTENSION 2 GRANTED
May 29, 2024 EX2G
SOU EXTENSION 2 FILED
May 29, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
May 29, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 24, 2023 EXRA
SOU EXTENSION 1 GRANTED
Nov 22, 2023 EX1G
SOU EXTENSION 1 FILED
Nov 22, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 22, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 30, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 4, 2023 NPUB
PUBLISHED FOR OPPOSITION
Apr 4, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 15, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 28, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 27, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 27, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 27, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 27, 2023 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Feb 24, 2023 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Feb 14, 2023 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 27, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 27, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 27, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 27, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 27, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 20, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 19, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 19, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 19, 2022 GNRN
NON-FINAL ACTION E-MAILED
Dec 19, 2022 GNRT
NON-FINAL ACTION WRITTEN
Dec 19, 2022 CNRT
ASSIGNED TO EXAMINER
Dec 12, 2022 DOCK
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Apr 13, 2022 ASGN
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 3, 2022 NWOS